Search

Author/Creator Kalvala, Arjun

3. The Bcl‐2 inhibitor venetoclax inhibits Nrf2 antioxidant pathway activation induced by hypomethylating agents in AML. Issue 8 (8th January 2019)

Authors:
Nguyen, Le Xuan Truong; Troadec, Estelle; Kalvala, Arjun; Kumar, Bijender; Hoang, Dinh Hoa; Viola, Domenico; Zhang, Bin; Nguyen, Dang Quan; Aldoss, Ibrahim; Ghoda, Lucy; Budde, Elizabeth; Pichiorri, Flavia; Rosen, Steven; Forman, Stephen J.; Marcucci, Guido; Pullarkat, Vinod
Journal:
Journal of cellular physiology
Issue:
Volume 234:Issue 8(2019:Aug.)
Page Start:
14040
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Type of TP53 mutation influences oncogenic potential and spectrum of associated K‐ras mutations in lung‐specific transgenic mice. Issue 9 (13th April 2019)

Authors:
Duan, Wenrui; Gao, Li; Kalvala, Arjun; Aguila, Brittany; Brooks, Christopher; Mo, Xiaokui; Ding, Haiming; Shilo, Konstantin; Otterson, Gregory A.; Villalona‐Calero, Miguel A.
Journal:
International journal of cancer
Issue:
Volume 145:Issue 9(2019)
Page Start:
2418
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗